德勤：2021年中国生物制药创新趋势展望报告（英文版）（80页）.pdf

《德勤：2021年中国生物制药创新趋势展望报告（英文版）（80页）.pdf》由会员分享，可在线阅读，更多相关《德勤：2021年中国生物制药创新趋势展望报告（英文版）（80页）.pdf（80页珍藏版）》请在三个皮匠报告上搜索。

1、Outlook on biopharmainnovation trends in ChinaJuly 2021Outlook on biopharma innovation trends in China | ContentsContentsPreface1. Innovative breakthroughs in the global biopharma industryBiopharma innovation is accelerating amid digital transformationApplication of AI in the entire medical industri

2、al chain is accelerating technical breakthroughsBiopharma enterprises R&D priorities are shifting to innovation of targets and the development of new-generation therapies2. Innovation trends in Chinas biopharma industryInnovative biologics are increasingly valued by government agencies; R&D and mark

3、et access are acceleratingChina becoming a digital transformation powerhouse for biopharma enterprisesInnovation breakthroughs as AI empowers the entire biopharma industrial chainNew-generation therapy: China a burgeoning market for CGTInnovation and implementation capabilities are shifting from MNC

4、s to local enterprises3. Conditions in Chinas biopharma industryRegulatory policies reform: the main areas and core policiesR&D models: innovative transformation and international cooperationLaunched products types: from universal innovation to leading innovationInvestment and M&A are creating innov

5、ative biopharma portfoliosFrom Importing to China to Exported from China4. Innovative biopharma development in the Yangtze River DeltaPolicy support: National and provincial policies promote regional integrationTalent accumulation: Top industrial talent is being brought in to accelerate scientific i

6、nnovation and reformCapital strength: Substantial capital support is being provided to enable innovative corporate development in the Yangtze River Delta5. Challenges and suggestions for biopharma innovation in ChinaEndnotes 1591215212124273034404145485153565660616770Outlook on biopharma innovation